Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Self-Recording of Eye Movements in Amyotrophic Lateral Sclerosis Patients Using a Smartphone Eye-Tracking App.
Barahim Bastani P, Saber Tehrani AS, Badihian S, Rieiro H, Rastall D, Farrell N, Parker M, Otero-Millan J, Hassoon A, Newman-Toker D, Clawson LL, Uchil A, Riley K, Zeiler SR. Barahim Bastani P, et al. Among authors: clawson ll. Digit Biomark. 2024 Jun 18;8(1):111-119. doi: 10.1159/000538992. eCollection 2024 Jan-Dec. Digit Biomark. 2024. PMID: 39015513 Free PMC article.
High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial.
Lewis RA, McDermott MP, Herrmann DN, Hoke A, Clawson LL, Siskind C, Feely SM, Miller LJ, Barohn RJ, Smith P, Luebbe E, Wu X, Shy ME; Muscle Study Group. Lewis RA, et al. Among authors: clawson ll. JAMA Neurol. 2013 Aug;70(8):981-7. doi: 10.1001/jamaneurol.2013.3178. JAMA Neurol. 2013. PMID: 23797954 Free PMC article. Clinical Trial.
Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral Sclerosis.
Quintana M, Saville BR, Vestrucci M, Detry MA, Chibnik L, Shefner J, Berry JD, Chase M, Andrews J, Sherman AV, Yu H, Drake K, Cudkowicz M, Paganoni S, Macklin EA; HEALEY ALS Platform Trial Study Group. Quintana M, et al. Ann Neurol. 2023 Sep;94(3):547-560. doi: 10.1002/ana.26714. Epub 2023 Jun 22. Ann Neurol. 2023. PMID: 37245090
A click-based electrocorticographic brain-computer interface enables long-term high-performance switch scan spelling.
Candrea DN, Shah S, Luo S, Angrick M, Rabbani Q, Coogan C, Milsap GW, Nathan KC, Wester BA, Anderson WS, Rosenblatt KR, Uchil A, Clawson L, Maragakis NJ, Vansteensel MJ, Tenore FV, Ramsey NF, Fifer MS, Crone NE. Candrea DN, et al. Commun Med (Lond). 2024 Oct 22;4(1):207. doi: 10.1038/s43856-024-00635-3. Commun Med (Lond). 2024. PMID: 39433597 Free PMC article.
A click-based electrocorticographic brain-computer interface enables long-term high-performance switch-scan spelling.
Crone N, Candrea D, Shah S, Luo S, Angrick M, Rabbani Q, Coogan C, Milsap G, Nathan K, Wester B, Anderson W, Rosenblatt K, Clawson L, Maragakis N, Vansteensel M, Tenore F, Ramsey N, Fifer M, Uchil A. Crone N, et al. Res Sq [Preprint]. 2023 Sep 25:rs.3.rs-3158792. doi: 10.21203/rs.3.rs-3158792/v1. Res Sq. 2023. Update in: Commun Med (Lond). 2024 Oct 22;4(1):207. doi: 10.1038/s43856-024-00635-3 PMID: 37841873 Free PMC article. Updated. Preprint.
Online speech synthesis using a chronically implanted brain-computer interface in an individual with ALS.
Angrick M, Luo S, Rabbani Q, Candrea DN, Shah S, Milsap GW, Anderson WS, Gordon CR, Rosenblatt KR, Clawson L, Maragakis N, Tenore FV, Fifer MS, Hermansky H, Ramsey NF, Crone NE. Angrick M, et al. medRxiv [Preprint]. 2023 Jul 1:2023.06.30.23291352. doi: 10.1101/2023.06.30.23291352. medRxiv. 2023. Update in: Sci Rep. 2024 Apr 26;14(1):9617. doi: 10.1038/s41598-024-60277-2 PMID: 37425721 Free PMC article. Updated. Preprint.
Stable Decoding from a Speech BCI Enables Control for an Individual with ALS without Recalibration for 3 Months.
Luo S, Angrick M, Coogan C, Candrea DN, Wyse-Sookoo K, Shah S, Rabbani Q, Milsap GW, Weiss AR, Anderson WS, Tippett DC, Maragakis NJ, Clawson LL, Vansteensel MJ, Wester BA, Tenore FV, Hermansky H, Fifer MS, Ramsey NF, Crone NE. Luo S, et al. Among authors: clawson ll. Adv Sci (Weinh). 2023 Dec;10(35):e2304853. doi: 10.1002/advs.202304853. Epub 2023 Oct 24. Adv Sci (Weinh). 2023. PMID: 37875404 Free PMC article.
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, Chiò A, Van Damme P, Ludolph AC, Glass JD, Andrews JA, Babu S, Benatar M, McDermott CJ, Cochrane T, Chary S, Chew S, Zhu H, Wu F, Nestorov I, Graham D, Sun P, McNeill M, Fanning L, Ferguson TA, Fradette S; VALOR and OLE Working Group. Miller TM, et al. N Engl J Med. 2022 Sep 22;387(12):1099-1110. doi: 10.1056/NEJMoa2204705. N Engl J Med. 2022. PMID: 36129998 Free article. Clinical Trial.
17 results